A novel oral ghrelin receptor agonist and calcium-sensitizing inotrope safely enhances stroke volume and cardiac output without triggering adverse arrhythmic events in HFrEF patients.
Most Recent Articles
Right Ventricular Free Wall Strain and Multiparametric Ultrasound Predictors of RVD in HFpEF
A combined six-parameter multiparametric echocardiographic model achieves excellent predictive accuracy for identifying right ventricular dysfunction in patients with heart failure and preserved ejection fraction.
Telehealth-Supported Home Exercise vs. Center-Based Rehabilitation in Lymphoma Survivors: A Randomized Trial
Telehealth-supported home exercise achieves equivalent cardiorespiratory fitness improvements to center-based care for lymphoma survivors while reducing rehabilitation costs by 48%.
Noninferiority of a Shorter 6-Month Multidrug Regimen for Rifampicin-Resistant Pulmonary Tuberculosis
Article Impact Level: HIGH Data Quality: STRONG Summary of New England Journal of Medicine Dr. Francesca Conradie et al. Points A landmark clinical trial conducted across South Africa successfully established that a shortened...
Target Trial Emulation Confirms Safety of Same-Day COVID-19 and Influenza Vaccine Coadministration
A comprehensive target trial emulation involving 2.5 million patients establishes that receiving same-day COVID-19 and influenza vaccinations does not increase the risk of serious adverse events.